ERBB2 and breast carcinoma: In addition, as the conjugation with colloidal nanoparticles seems to affect the therapeutic efficacy of TZ13, we explored the anticancer activity of MNP-HC both in HER2+ TZ-sensitive and resistant breast cancer cells.